Principal Investigator, MJFF
"Building a presence as a world-renowned biobanking institution across six decades has been one of Coriell's chief legacies. By insisting on gold-standards for quality and service, we've been able to fuel important scientific breakthroughs around the globe."
Dorit S. Berlin, PhD, is director of biobanking at Coriell. In this role, Dorit provides strategic and operational leadership for all scientific and business biobanking processes, including core laboratory operations, government contract initiatives, and biobanking logistics.
Dorit is also principal investigator for projects supported by the Michael J. Fox Foundation for Parkinson's Research (MJFF), focusing largely on the Parkinson's Progression Markers Initiative (PPMI), a multi-center study that brings together clinicians, researchers, and study participants from all over the world to accelerate the discovery and validation of biomarkers of Parkinson's disease progression.
Prior to joining Coriell, Dorit was a postdoctoral scholar at Stanford University, where she worked on scientific curation for the Pharmacogenomics Knowledge Base, synthesizing pharmacogenomic knowledge, generating database and website content, and participating in external collaborations. Dorit also founded and led an education project to create DNATwist (www.dnatwist.org), a web-based pharmacogenomics teaching module.
Dorit earned her undergraduate degree in chemistry from the Massachusetts Institute of Technology and her doctorate in molecular and cell biology from the University of California, Berkeley.